PharmaCorp Rx Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	55	63	4	12	-
Market Cap Growth	1263.43%	1387.38%	-64.51%	-	-
Enterprise Value	44	38	2	9	-
Last Close Price	0.48	0.54	0.21	0.60	-
PS Ratio	5.65	10.93	-	-	-
PB Ratio	1.80	2.07	1.87	4.42	-
P/TBV Ratio	3.92	4.61	1.87	4.42	-
P/FCF Ratio	134.98	536.42	-	-	-
P/OCF Ratio	124.70	506.85	-	-	-
EV/Sales Ratio	4.44	6.54	-	-	-
EV/FCF Ratio	106.23	321.02	-	-	-
Debt / Equity Ratio	0.03	0.03	-	-	-
Debt / FCF Ratio	2.23	8.07	-	-	-
Asset Turnover	0.52	0.31	-	-	-
Quick Ratio	7.63	7.79	48.54	166.01	37.20
Current Ratio	8.58	8.59	50.24	166.01	37.98
Return on Equity (ROE)	-3.61%	-6.40%	-18.85%	-28.02%	-
Return on Assets (ROA)	-3.77%	-5.29%	-14.29%	-18.85%	-
Return on Capital (ROIC)	-4.19%	-5.88%	-14.47%	-19.07%	-
Earnings Yield	-1.03%	-1.60%	-11.05%	-4.31%	-
FCF Yield	0.74%	0.19%	-12.20%	-1.00%	-
Buyback Yield / Dilution	-468.56%	-303.02%	-1.39%	-23.69%	-

Updated Nov 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.